Global import network The MPA Pharma group operates a broad cross-border distribution model (Germany and Scandinavia) via EMRAmed and Paranova, suggesting a strong channel for expanding into Northern Europe and leveraging parallel import capabilities for new product lines.

Contract manufacturing potential As an authorised pharmaceutical manufacturer with GMP compliance and extensive QA controls, MPA Pharma offers contract manufacturing services that could be a pathway to onboard new custom manufacturing projects or private-labeled products.

Quality trust signals Emphasize their commitment to safety, quality, and regulatory compliance (GMP, GDP, EU/EMA guidelines) to position as a reliable partner for high-regulatory or specialty APIs and registered medicines, appealing to suppliers and co-manufacturers seeking rigorous standards.

Mid-market footprint With 51-200 employees and revenue in the 10–25 million USD range, there is a solid mid-market presence ideal for scalable partnerships, distribution deals, and joint ventures in regulated European markets.

Tech and operations fit Existing tech stack (ERP/HRIS with iCIMS, Microsoft 365, Adobe suite, Apache servers) indicates readiness to integrate new supplier portals, order automation, and digital contract workflows to streamline procurement, QA documentation, and regulatory filings.